| | PTU Discouraged For Children With Graves DiseaseThe Endocrine Society has endorsed a recommendation to curtail the use of propylthiouracil as a first-line agent in children with Graves disease. PII: S1558-0164(09)70130-0 © 2009 Elsevier Inc. All rights reserved. | |
|
|